Skip to main content
padlock icon - secure page this page is secure

Antibacterial Effect of Lanthanum Calcium Manganate (La0.67Ca0.33MnO3) Nanoparticles Against Pseudomonas aeruginosa ATCC 27853

Buy Article:

$106.65 + tax (Refund Policy)

Nanotechnology based water purification system and treatment of human diseases are of higher priority in the immediate future for economic and undetermined health purpose. Nanoparticles offer the possibility of an efficient removal of pollutants and microbes in water treatment. Here we have used colossal magnetoresistance (CMR) materials, lanthanum calcium manganate (LCMO) and Eu3+ doped lanthanum calcium manganate (LECMO) nanoparticles, to determine the antibacterial efficacy against Pseudomonas aeruginosa-ATCC 27853, a soil and water born pathogenic bacteria. The average size of the synthesized nanoparticles was varied from 50 nm to 200 nm and X-ray diffraction pattern showed the formation of a single phase LCMO or LECMO of an orthorhombic crystal structure after annealing the precursor at 1000 °C for 2 h in air. The data revealed that LCMO nanoparticle have higher antibacterial activity compared to LECMO nanoparticle. Thus, LCMO nanoparticles can offer future applications as antimicrobial drug and in water purification technology.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: ANTIBACTERIAL ACTIVITY; COLOSSAL MAGNETORESISTANCE (CMR) MATERIALS; EU3+ DOPED LANTHANUM CALCIUM MANGANATE (LECMO); LANTHANUM CALCIUM MANGANATE (LCMO); PSEUDOMONAS AERUGINOSA

Document Type: Research Article

Publication date: April 1, 2010

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more